Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Ionis Pharmaceuticals

    World Rank (Aug-2026)
    2,279
    Market Cap (Aug-2026)
    9.512 Billion USD
    World Rank (Jan-05-2024)
    2,137
    Market Cap (Jan-05-2024)
    7.403 Billion USD
    World Rank (Jul-30-2023)
    2,651
    Market Cap (Jul-30-2023)
    5.694 Billion USD
    World Rank (Dec-25-2022)
    2,556
    Market Cap (Dec-25-2022)
    5.421 Billion USD
    World Rank (Jan-07-2022)
    3,683
    Market Cap (Jan-07-2022)
    4.29 Billion USD
    Annual Revenue in USD
    944 Million USD
    Annual Operating Income in USD
    -382 Million USD
    Annual Net Income in USD
    -381 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Biotechnology company with headquarters is in USA.

  2. Crinetics Pharmaceuticals

    World Rank (Aug-2026)
    2,387
    Market Cap (Aug-2026)
    8.984 Billion USD
    World Rank (Jan-05-2024)
    5,177
    Market Cap (Jan-05-2024)
    2.335 Billion USD
    World Rank (Jul-30-2023)
    8,660
    Market Cap (Jul-30-2023)
    1.015 Billion USD
    World Rank (Dec-25-2022)
    8,927
    Market Cap (Dec-25-2022)
    0.899 Billion USD
    World Rank (Jan-07-2022)
    8,518
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Operating Income in USD
    -517 Million USD
    Annual Net Income in USD
    -465 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Crinetics Pharmaceuticals is a Pharmaceutical company that develops much needed therapies for people with rare endocrine diseases. The company annual revenue is 131.7 million USD and 47 employees. The headquarters is in USA.
  3. Vaxcyte Inc.

    World Rank (Aug-2026)
    2,456
    Market Cap (Aug-2026)
    8.641 Billion USD
    World Rank (Jan-05-2024)
    2,495
    Market Cap (Jan-05-2024)
    6.122 Billion USD
    World Rank (Jul-30-2023)
    3,324
    Market Cap (Jul-30-2023)
    4.376 Billion USD
    World Rank (Dec-25-2022)
    3,506
    Market Cap (Dec-25-2022)
    3.686 Billion USD
    World Rank (Jan-07-2022)
    8,241
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Operating Income in USD
    -924 Million USD
    Annual Net Income in USD
    -767 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Vaxcyte is a Biotechnology company developing potentially superior and novel vaccines designed to prevent or treat the most common and deadly infectious diseases worldwide. It is having 43 employees as on 2019. The headquarters is in USA.

  4. Immunovant

    World Rank (Aug-2026)
    2,458
    Market Cap (Aug-2026)
    8.638 Billion USD
    World Rank (Jan-05-2024)
    2,674
    Market Cap (Jan-05-2024)
    5.626 Billion USD
    World Rank (Jul-30-2023)
    4,418
    Market Cap (Jul-30-2023)
    2.942 Billion USD
    World Rank (Dec-25-2022)
    7,090
    Market Cap (Dec-25-2022)
    1.328 Billion USD
    World Rank (Jan-07-2022)
    9,880
    Market Cap (Jan-07-2022)
    0.92 Billion USD
    Annual Net Income in USD
    -506 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    Company Profile
    Immunovant is a Clinical Stage Biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The headquarters is in USA.
  5. Alkermes

    World Rank (Aug-2026)
    2,545
    Market Cap (Aug-2026)
    8.230 Billion USD
    World Rank (Jan-05-2024)
    3,032
    Market Cap (Jan-05-2024)
    4.784 Billion USD
    World Rank (Jul-30-2023)
    3,088
    Market Cap (Jul-30-2023)
    4.778 Billion USD
    World Rank (Dec-25-2022)
    3,161
    Market Cap (Dec-25-2022)
    4.188 Billion USD
    World Rank (Jan-07-2022)
    3,992
    Market Cap (Jan-07-2022)
    3.88 Billion USD
    Annual Revenue in USD
    1,111 Million USD
    Annual Operating Income in USD
    -142 Million USD
    Annual Net Income in USD
    -158 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. Headquarters is in Dublin, Ireland.

    Alkermes seeks to develop innovative medicines that help address the unmet needs and challenges of people living with debilitating diseases.

    The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer.

  6. Rhythm Pharmaceuticals

    World Rank (Aug-2026)
    2,615
    Market Cap (Aug-2026)
    7.951 Billion USD
    World Rank (Jan-05-2024)
    4,844
    Market Cap (Jan-05-2024)
    2.594 Billion USD
    World Rank (Jul-30-2023)
    8,637
    Market Cap (Jul-30-2023)
    1.018 Billion USD
    World Rank (Dec-25-2022)
    6,150
    Market Cap (Dec-25-2022)
    1.648 Billion USD
    World Rank (Jan-07-2022)
    13,819
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    190 Million USD
    Annual Operating Income in USD
    -192 Million USD
    Annual Net Income in USD
    -197 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Rhythm is a Biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. The headquarters is in USA.
  7. Grifols S.A.

    World Rank (Aug-2026)
    2,630
    Market Cap (Aug-2026)
    7.879 Billion USD
    World Rank (Jan-05-2024)
    1,723
    Market Cap (Jan-05-2024)
    9.535 Billion USD
    World Rank (Jul-30-2023)
    1,788
    Market Cap (Jul-30-2023)
    9.235 Billion USD
    World Rank (Dec-25-2022)
    2,512
    Market Cap (Dec-25-2022)
    5.513 Billion USD
    World Rank (Jan-07-2022)
    1,735
    Market Cap (Jan-07-2022)
    11.02 Billion USD
    Annual Revenue in USD
    6,685 Million USD
    Annual Operating Income in USD
    774 Million USD
    Annual Net Income in USD
    229 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and healthcare company with headquarters is in Barcelona, Spain.

  8. TG Therapeutics

    World Rank (Aug-2026)
    2,738
    Market Cap (Aug-2026)
    7.461 Billion USD
    World Rank (Jan-05-2024)
    4,673
    Market Cap (Jan-05-2024)
    2.728 Billion USD
    World Rank (Jul-30-2023)
    4,415
    Market Cap (Jul-30-2023)
    2.943 Billion USD
    World Rank (Dec-25-2022)
    7,601
    Market Cap (Dec-25-2022)
    1.180 Billion USD
    World Rank (Jan-07-2022)
    5,472
    Market Cap (Jan-07-2022)
    2.50 Billion USD
    Annual Revenue in USD
    616 Million USD
    Annual Operating Income in USD
    123 Million USD
    Annual Net Income in USD
    447 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    TG Therapeutics is a Biopharmaceutical company. The company annual revenue is less than 1 million USD and 217 employees. The headquarters is in USA.
  9. Liquidia Corporation

    World Rank (Aug-2026)
    2,956
    Market Cap (Aug-2026)
    6.663 Billion USD
    World Rank (Jan-05-2024)
    9,521
    Market Cap (Jan-05-2024)
    0.840 Billion USD
    World Rank (Jul-30-2023)
    14,180
    Market Cap (Jul-30-2023)
    0.396 Billion USD
    Annual Revenue in USD
    158 Million USD
    Annual Operating Income in USD
    -51 Million USD
    Annual Net Income in USD
    -69 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  10. Cogent Biosciences Inc.

    World Rank (Aug-2026)
    2,985
    Market Cap (Aug-2026)
    6.582 Billion USD
    World Rank (Jan-05-2024)
    12,548
    Market Cap (Jan-05-2024)
    0.504 Billion USD
    World Rank (Jul-30-2023)
    8,448
    Market Cap (Jul-30-2023)
    1.061 Billion USD
    World Rank (Dec-25-2022)
    9,806
    Market Cap (Dec-25-2022)
    0.768 Billion USD
    World Rank (Jan-07-2022)
    16,133
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Operating Income in USD
    -333 Million USD
    Annual Net Income in USD
    -329 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Cogent Biosciences, Inc is a biotechnology company developing real solutions to treat genetically driven diseases. The headquarters is in USA.

    Facts About Company

    Cogent Biosciences, Inc Annual Net loss for year ending Dec-2022 was -140 million USD.

    Cogent Biosciences, Inc Annual Net loss for year ending Dec-2021 was -72 million USD.

    As on 2022, Cogent Biosciences, Inc has 138 employees.

Share

Ads